DKLRF yields 181818.18% · JNJ yields 2.14%● Live data
📍 DKLRF pulled ahead of the other in Year 1
Combined, DKLRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DKLRF + JNJ for your $10,000?
Decklar Resources Inc. operates as an independent international oil and gas company in Nigeria and Canada. The company explores for copper, lead, and zinc deposits. It focuses on appraisal and development in the West African region. The company holds interests in the Oza Oil Field that covers an area of 20 square kilometers located onshore in the northern part of Oil Mining Lease (OML) 11 in Nigeria's Eastern Niger Delta; the Asaramatoru Field located onshore in the southern swamp section of OML 11 in the Eastern Niger Delta; and the Emohua Oil Field located onshore in the southeastern section of OML 22 in the Eastern Niger Delta. It also holds an option to acquire a 75% interest in the Holt property that covers an area of 3,687 hectares located in east of Duncan, British Columbia. It also provides funding and technical advisory services to exploration and development companies The company was formerly known as Asian Mineral Resources Limited and changed its name to Decklar Resources Inc. in September 2020. Decklar Resources Inc. was incorporated in 2004 and is based in Toronto, Canada.
Full DKLRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.